Multiple sclerosis journal - experimental, translational and clinical

MSJ-ETC Editorial -- The relationship between objective parameters of sleep and measures of fatigue, depression, and cognition in multiple sclerosis -- Safety, tolerability and pharmacodynamics of a novel immunomodulator, MIS416, in patients with chronic progressive multiple sclerosis -- Effects of a DVD-delivered exercise intervention on physical function in older adults with multiple sclerosis: A pilot randomized controlled trial -- Adherence to behavioural interventions in multiple sclerosis: Follow-up meeting report (AD@MS-2) -- Cannabis-induced alterations in brain activation during a test of information processing speed in patients with MS -- Evolving role of MRI in optimizing the treatment of multiple sclerosis: Canadian Consensus recommendations -- Assessing clinical correlates of self-rated disability in patients with multiple sclerosis -- Incidence of acute disseminated encephalomyelitis in the Jiangsu province of China, 2008-2011 -- Heterogeneity of sickness absence and disability pension trajectories among individuals with MS -- Introducing a new method to assess vision: Computer-adaptive contrast-sensitivity testing predicts visual functioning better than charts in multiple sclerosis patients -- Association of plasma levels of Protein S with disease severity in multiple sclerosis -- Identifying an important change estimate for the Multiple Sclerosis Walking Scale-12 (MSWS-12v1) for interpreting clinical trial results -- Dimethyl fumarate-associated lymphopenia: Risk factors and clinical significance -- Multiple sclerosis in Latin America: A different disease course severity? A collaborative study from the MSBase Registry -- Treatment discontinuation in multiple sclerosis: The French Web-based survey ALLIANCE -- Detection of cortical lesions in multiple sclerosis: A new imaging approach -- Improved working ability in a contemporary MS population compared with a historic non-treated MS population in the same geographic area of Sweden -- Evaluation of an integrated multidisciplinary approach in multiple sclerosis care: A prospective, randomized, controlled study -- Remotely-delivered cognitive remediation in multiple sclerosis (MS): protocol and results from a pilot study -- A randomized trial of teriflunomide added to glatiramer acetate in relapsing multiple sclerosis -- Free kappa light chains in cerebrospinal fluid as a biomarker to assess risk conversion to multiple sclerosis -- Predicting optimal response to B-cell depletion with rituximab in multiple sclerosis using CXCL13 index, magnetic resonance imaging and clinical measures -- Improvement to baseline after plasma exchange in spinal attacks associated with neuromyelitis optica.